Jornal de Microbiologia Alimentar

Abstrato

Bifidobacteria probiotic: prevention and treatment of obesity.

Priyanka Dhyani

Obesity has become a severe public health problem in recent decades, impacting both children and adults. The most prevalent cause is an imbalance in energy intake and expenditure. Obesity is linked to changes in the function and makeup of the gut microbiota, according to scientific research. The gut microbiome of healthy persons differs from that of lean people. As a result, the gut microbiota can be adjusted to achieve optimum health. Obesity is linked to alterations in the Bacteriodetes and Formicates bacterial divisions. Formicates are a sign of obesity, but bifido is a sign of a healthy weight speciality. As a result, the gut microbiota, an important pathophysiological component, plays a key role in obesity development. Changing the gut flora has the ability to increase or reduce body weight and BMI (BMI). Probiotics have been found to alter the makeup of the gut microbiota, increase gut integrity, and reverse obesity-related microbial shifts. As a result, probiotics have been proposed as a potential approach for preventing and treating obesity. The greatest answer to the problem is to control the diet and lifestyle factors that promote obesity development. The goal of this study is to examine the huge amount of evidence available on the composition, function, and alternations of the gut microbiota in obesity, Bifidobacterium?s antiobesity benefits, probiotics for treating obesity, and the field's future prospects.

Isenção de responsabilidade: Este resumo foi traduzido usando ferramentas de inteligência artificial e ainda não foi revisado ou verificado.